 |
answer text |
<p>The UK is a world-leader in the development and manufacture of cell and gene therapies
thanks to government investment in innovation and skills, including through the Cell
and Gene Therapy Catapult (CGTC).</p><p> </p><p>DSIT also invested £10 million - alongside
£10 million from Scottish Enterprise – to support a new Oligonucleotide Manufacturing
Innovation Centre of Excellence in Glasgow.</p><p> </p><p>The Vaccine Taskforce provided
funding for a state-of-the art CGTC facility in Braintree to accelerate the development
and manufacturing of advanced therapies at clinical and commercial scale.</p><p> </p><p>My
department also supported CGTC to establish apprenticeships and training programmes
to upskill people across the UK.</p>
|
 |
